2 outlets covering this story
Reports Detail AI Breach in Australia and Safety Issues in Celldex Drug Trial
By Rhyter Times Desk · 2h ago
According to reporting from The New York Times, the Australian government was recently compromised in an electronic intrusion executed with artificial intelligence utilities. The cyber incident has intensified existing international apprehensions regarding the deployment and risks of AI technology.
Separately, BioPharma Dive reported that Celldex faced a sharp decline as safety issues overshadowed clinical findings for its immune drug, barzolvolimab. While an analyst noted that the candidate yielded the strongest efficacy demonstrated so far against chronic skin hives, the therapy was linked to two life-threatening instances of anaphylaxis.
How outlets are covering this
Recent news reports highlight emerging safety issues across technology and healthcare. The New York Times reported that an artificial intelligence-driven hack struck the Australian government, compounding international worries about AI. Separately, BioPharma Dive reported that Celldex suffered a setback after two life-threatening anaphylaxis cases emerged in trials for its skin hive treatment barzolvolimab, despite record efficacy.
Create a free account to keep reading
Reporting is our own AI-assisted writing, synthesized from the outlets sourced below. A free account gets you 3 of these a month, no payment needed.
Or keep browsing our free aggregated sections in the meantime.
Sources
- A.I. Safety Concerns Go Global
The new york times · 2h ago
- Celldex sinks as safety concerns cloud immune drug results
Biopharma dive · 1d ago
Written by AI from the outlets' reporting listed below.
Last updated 2h ago.